Document/ExhibitDescriptionPagesSize
1: 10-Q Quarterly Report HTML 692K
2: EX-10.1 Material Contract HTML 366K
3: EX-10.2 Material Contract HTML 30K
4: EX-10.3 Material Contract HTML 22K
5: EX-10.4 Material Contract HTML 22K
6: EX-10.5 Material Contract HTML 40K
7: EX-10.6 Material Contract HTML 31K
8: EX-31.1 Certification -- §302 - SOA'02 HTML 24K
9: EX-31.2 Certification -- §302 - SOA'02 HTML 23K
10: EX-32.1 Certification -- §906 - SOA'02 HTML 23K
17: R1 Cover HTML 73K
18: R2 Condensed Balance Sheets HTML 105K
19: R3 Condensed Balance Sheets (Parenthetical) HTML 38K
20: R4 Unaudited Condensed Statements of Operations HTML 82K
21: R5 Unaudited Condensed Statements of Stockholders' HTML 100K
Equity
22: R6 Unaudited Condensed Statements of Stockholders' HTML 20K
Equity (Parenthetical)
23: R7 Unaudited Statements of Cash Flows HTML 108K
24: R8 Organization HTML 24K
25: R9 Summary of Significant Accounting Policies HTML 109K
26: R10 Other Financial Information HTML 51K
27: R11 Borrowings HTML 38K
28: R12 Commitment and Contingencies HTML 29K
29: R13 Fair Value Measurements HTML 34K
30: R14 Stockholders' Equity HTML 39K
31: R15 Stock Option Plan HTML 79K
32: R16 Covid-19 HTML 25K
33: R17 Subsequent Events HTML 23K
34: R18 Summary of Significant Accounting Policies - HTML 65K
(Policies)
35: R19 Summary of Significant Accounting Policies - HTML 94K
(Tables)
36: R20 Other Financial Information - (Tables) HTML 54K
37: R21 Borrowings - (Tables) HTML 27K
38: R22 Fair Value Measurements (Tables) HTML 33K
39: R23 Stockholders' Equity (Tables) HTML 33K
40: R24 Stock Option Plan (Tables) HTML 86K
41: R25 Organization - (Details) HTML 25K
42: R26 Summary of Significant Accounting Policies - HTML 39K
Revenue by Major Payers (Details)
43: R27 Summary of Significant Accounting Policies - HTML 84K
Narrative (Details)
44: R28 Summary of Significant Accounting Policies - HTML 35K
Disaggregation of Revenue (Details)
45: R29 Summary of Significant Accounting Policies - Cash, HTML 27K
cash equivalents and restricted cash (Details)
46: R30 Summary of Significant Accounting Policies - HTML 32K
Securities (Details)
47: R31 Other Financial Information - Prepaid expenses HTML 31K
(Details)
48: R32 Other Financial Information - Property and HTML 38K
equipment (Details)
49: R33 Other Financial Information - Narrative (Details) HTML 26K
50: R34 Other Financial Information - Accrued and other HTML 38K
current liabilities (Details)
51: R35 Borrowings - Narrative (Details) HTML 53K
52: R36 Borrowings - Future minimum payments (Details) HTML 39K
53: R37 Commitment and Contingencies - Narrative (Details) HTML 67K
54: R38 Fair Value Measurements (Details) HTML 29K
55: R39 Stockholders' Equity - Narrative (Details) HTML 44K
56: R40 Stockholders' Equity (Details) HTML 38K
57: R41 Stock Option Plan - Narrative (Details) HTML 41K
58: R42 Stock Option Plan - Stock Option Activity HTML 75K
(Details)
59: R43 Stock Option Plan - Restricted Stock Units HTML 48K
(Details)
60: R44 Stock Option Plan - Fair Value Assumptions HTML 51K
(Details)
61: R45 Stock Option Plan - Stock-Based Compensation HTML 29K
Expense (Details)
62: R46 Covid-19 (Details) HTML 30K
63: R47 Subsequent Events - Narrative (Details) HTML 40K
65: XML IDEA XML File -- Filing Summary XML 107K
16: XML XBRL Instance -- exdx-20210930_htm XML 1.45M
64: EXCEL IDEA Workbook of Financial Reports XLSX 76K
12: EX-101.CAL XBRL Calculations -- exdx-20210930_cal XML 126K
13: EX-101.DEF XBRL Definitions -- exdx-20210930_def XML 500K
14: EX-101.LAB XBRL Labels -- exdx-20210930_lab XML 1.34M
15: EX-101.PRE XBRL Presentations -- exdx-20210930_pre XML 774K
11: EX-101.SCH XBRL Schema -- exdx-20210930 XSD 127K
66: JSON XBRL Instance as JSON Data -- MetaLinks 334± 474K
67: ZIP XBRL Zipped Folder -- 0001274737-21-000115-xbrl Zip 340K
This Second Amendment of Lease is made on October 11, 2021, between Liberty Vista, a California limited partnership, ("Lessor"), whose address is 1000 Pioneer Way, El Cajon, CA92020, and Exagen
Diagnostics, Inc., ("Lessee"), with reference to 1221 Liberty Way, San Diego, CA92083 who agree as follows:
1.Recitals. This Second Amendment of Lease is made with reference to the following facts and objectives:
a.Lessor and Lessee entered into a written Lease dated August 15, 2014, as extended February 1, 2018, February 25, 2020, as amended December30, 2020 ("the Lease") in which Lessor leased to Lessee, and Lessee leased from Lessor, premises located
in the City of Vista, County of San Diego, California, commonly known as 1221 Liberty Way, Vista, CA92083, consisting of approximately 19,504 square feet (“Premises”).
c.The parties desire to amend the Lease in the following respect:
2.Extension of Term. The term of the Lease shall be extended for an additional period of one (1) year and three (3) months from
and after February 1, 2026, so that the term of the Lease shall extend to and include April 30, 2027.
3.Base Monthly Rent Schedule. Base monthly rent for the current and extended term shall be as follows:
4.Lessor Ownership Correction. The Lessor of the premises erroneously appeared as “Liberty Vista, a California limited partnership”. The correct Lessor name is "Liberty Vista, LP, a California limited partnership". The Lessor name is hereby corrected throughout the Lease.
5.Lessee Name Change. The Lessee's name shall change
from Exagen Diagnostics, Inc., a California corporation to Exagen Inc. a California corporation.
6.Counterparts. The Amendment may be signed by the parties in different counterparts and the signature pages combined shall create a single document binding on all parties. This Amendment may be executed and delivered by the exchange of .pdf or using electronic signature technology (e.g., via DocuSign or similar electronic signature technology), and such signed electronic record shall be valid and bind the party so signing as a such party's hand-written signature for all purposes.
7.Effectiveness of Lease. Except as set forth in this Second Amendment of Lease, all the provisions of the Lease shall remain unchanged and in full force and effect.
